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ECONOMIC ANALYSIS OF A LARGE SCALE ORAL 
VACCINATION PROGRAM TO CONTROL RACCOON 
RABIES
PHILIP KEMERE, MICHAEL K. LIDDEL, PHYLO EVANGELOU, DENNIS SLATE 
AND STEVEN OSMEK
Abstract: Since the late 1980s, results of oral vaccination trials in several states have provided growing evidence that this 
vaccination method may be effective for controlling the spread of rabies in raccoons (Procyon lotor). This study examines 
the economic feasibility of using oral vaccination on a larger scale than previous trials. We analyze the benefits and costs 
associated with a hypothetical barrier that would stretch from Lake Erie to the Gulf of Mexico, combining natural geographic 
features provided by the Appalachian Mountains with oral vaccination zones. The goal of this barrier would be to prevent the 
raccoon rabies variant from moving west into broader geographic regions of the United States. The costs of establishing and 
maintaining this hypothetical barrier are compared to the avoided costs of not having to live with raccoon rabies west of its 
current distribution. The westward advance of raccoon rabies, if it is not contained, is projected using simple models based 
on constant rates of spread. Our results show that preventing the westward movement of raccoon rabies by combining an 
oral vaccination program with natural barriers may be economically feasible. Discounted costs of establishing and maintaining 
the barrier are estimated to total between US$58 million and US$148 million. Net benefits of program implementation range 
between US$48 million and US$496 million for a variety of models, including ones that exclude forgone pet vaccination 
expenditures. The analysis also provides a framework for developing future models to explore the benefits and costs of 
eliminating raccoon rabies from currently affected areas.
Key Words: barrier, cost-benefit, economics, oral vaccination, ORV, Procyon lotor, rabies, Raboral V-RG®, raccoon.
Reported cases of animal rabies in the United 
States have nearly doubled in the last 30 years, with 
most of the increase attributable to the spread of rac-
coon rabies in the northeastern states. The raccoon epi-
zootic has spread east and north from the Virginia/West 
Virginia border and has also converged with raccoon 
rabies in the Carolinas (Krebs et al. 1998). In the past 
21 years, all of the mid-Atlantic and New England states 
have experienced at least one outbreak. The raccoon 
rabies epizootic front reached Maine in 1994, reflecting 
a movement rate of about 30 to 35 miles per year (48.3 
km/yr). It was also first confirmed in northeastern Ohio 
in 1996 (Krebs et al. 1998). In 1999, the first three cases 
of raccoon rabies were confirmed in southern Ontario 
(MacInnes, Ontario Ministry of Natural Resources, pers 
com). 
Several states and jurisdictions have implemented 
oral rabies vaccination (ORV) programs using the 
vaccine Raboral V-RGÒ either to attempt to halt the 
advance of raccoon rabies or eliminate or reduce it. 
These areas include: Pinellas County, Florida; Cape Cod, 
Massachusetts; Cape May, New Jersey; portions of New 
York, Vermont and Ohio, and recently, Anne Arundel 
County, Maryland and Fairfax, Virginia. In addition, 
Raboral V-RGÒ has been used with success to control 
rabies in coyotes (Fearneyhough et al. 1998) and gray 
foxes in Texas (Fearneyhough and Wilson 2000). Data 
from these site-specific programs provide a basis for 
considering larger scale control efforts. 
Raccoon rabies presents a human health threat 
though potential direct exposure to rabid raccoons, or 
indirectly through the exposure of a pet to rabid rac-
coons. To date, there have been no known cases of 
rabies in humans attributable to raccoon rabies. How-
ever, the number of pets and livestock examined and 
vaccinated for rabies, the number of tests requested, 
and the number of post-exposure treatments are all 
greater when raccoon rabies is present. Human and 
financial resources allocated to rabies-related human 
and animal health needs also increase, often at the 
expense of other important activities. 
The westward movement of the raccoon rabies 
front has slowed, probably in response to both natural 
geographic and man-made barriers. The Appalachian 
mountains and perhaps river systems flowing eastward 
have helped confine the raccoon variant to the eastern 
United States. In northeast Ohio, an ORV program has 
established an “immune barrier” along its border with 
Pennsylvania from the Lake Erie to the Ohio River near 
East Liverpool, Ohio that has slowed if not stopped 
the westward expansion of raccoon rabies. If raccoon 
rabies breaches this barrier, current raccoon live trap-
ping results in Ohio (Montoney, personal communica-
tion) as well as the status of raccoons in the Midwest 
(Sanderson and Hubert 1982, Glueck et al. 1988, Has-
brouck et al. 1992, Mosillo et al. 1999) suggest that 
populations are sufficient for rabies to spread westward 
along a front, similar to or more rapidly (Rupprecht and 
Smith 1994) than it has in the eastern United States. 
For this analysis we refer to two regions of the 
United States. The first region consists of the states that 
are already affected by raccoon rabies (epizootic/post-
epizootic states). These are primarily the mid-Atlantic, 
New England, and eastern seaboard states, although 
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portions of Florida and Georgia in particular have had 
enzootic rabies for 40 to 50 years or more and may be 
thought of as post-epizootic states within the affected 
eastern US. The second region consists of the Midwest 
and Plains states, out to the Rocky Mountains that have 
never experienced raccoon variant of rabies (pre-epizo-
otic states). 
The presence of the raccoon rabies variant has 
been shown to dramatically increase the incidence 
of rabies, and may present a higher exposure risk 
than other variants. Krebs et al. (1998) reports that 
6,563 of the 8,513 reported animal rabies cases in the 
United States in 1997 were from states that had experi-
enced raccoon rabies (epizootic/post-epizootic states) 
and 1,238 were from states currently unaffected by the 
raccoon variant (pre-epizootic states). In both regions, 
wild animal infections were dominant. However, there 
were more infected domestic cats and dogs reported 
in epizootic/post-epizootic states than in pre-epizootic 
states. Of the 6,210 wild animal cases reported in epizo-
otic region, 4,276 were raccoon cases. The epizootic 
states also reported more skunk, fox, and bat cases than 
did the pre-epizootic states.
ASSUMPTIONS
This analysis examines a hypothetical barrier 
against the spread of raccoon rabies. Higher elevations 
of the Appalachian Mountains are assumed to form por-
tions of this barrier. This assumption is based in large 
part on the pattern for raccoon rabies spread from 
West Virginia in the late 1970s. From that focus, rac-
coon rabies moved generally north and east. Presumably 
this pattern of spread was due in part to the effect 
of poorer raccoon habitats at higher elevations in the 
Appalachians which served as natural barriers to the 
westerly movement of the disease (Rupprecht and Smith 
1994). 
In addition, models and results rely heavily on sev-
eral other basic assumptions. We assume that without 
intervention the raccoon rabies variant would spread 
westward across the Midwest and Plains states. Ohio 
has recently encountered the raccoon rabies variant in 
areas near its eastern border, and established an ORV 
program to attempt to contain it. Ohio experienced 
a breach in its barrier in 1999. The barrier was subse-
quently widened with no additional cases of raccoon 
variant west of the current vaccination barrier (Smith, 
personal communication). Also, there has recently been 
evidence of raccoon rabies crossing the Alabama River 
and entering the western part of Alabama (W. B. John-
ston, Alabama Department of Public Health, personal 
communication). 
The second main assumption is that the conse-
quences of the raccoon rabies variant entering the Mid-
west and Plains states would be similar to what has 
been experienced by states already affected, despite 
demographic and ecological differences between the 
affected and unaffected states. As raccoon rabies occu-
pies a broader geographic area, there is an expectation 
of greater numbers of rabies cases in other wild and 
domestic animals, along with the increase in raccoon 
rabies cases. Although the pre-epizootic Midwest and 
Plains states collectively have a lower human population 
and per capita income, they have a larger land area 
and more domestic livestock than the states currently 
affected by the raccoon rabies variant. These states also 
have the capacity to support abundant raccoon popula-
tions (Stuewer 1943, Twitchell and Dill 1949, Urban 
1970, Schinner and Gauley 1974, Sanderson and Hubert 
1982, Glueck et al. 1988, Hasbrouck et al. 1992, Mosillo 
et al. 1999). These factors could affect the movement 
of the raccoon rabies variant, and the impact it has 
on human populations. However, without specific data 
on how the epizootic will spread, we assume that the 
impacts will be similar to the states already affected. 
Additionally, we assume that current methods of 
oral rabies vaccination can effectively contain the rac-
coon rabies variant. Studies on the effectiveness of ORV 
in several states have shown that the methods used 
appear to be effective. Specifically, the ORV program 
in Ohio against raccoon rabies and the ORV program 
in Texas against coyote rabies have had good results 
(Fearneyhough et al. 1998, Collart 2000). Implicit in 
this assumption is that translocation of a rabid raccoon 
into the unaffected areas would not occur, or would not 
lead to establishment of the raccoon rabies variant as 
was documented in West Virginia in the 1970s (Nettles 
et al. 1979).
METHODS
Benefits and costs are monetized in a cost-benefit 
framework. Benefits are all costs, including direct med-
ical and nonmedical costs, that would be avoided 
as a result of the proposed ORV program. Other 
indirect avoided costs such as time lost due to prophy-
laxis, potential adverse effects of the oral vaccine, busi-
ness losses due to decreased recreational activities in 
affected areas, and the value of potential lost life are not 
included. These would all raise the expected benefit. 
The benefits result from preventing the adverse 
effects of the epizootic, and related expenditures to 
manage and control it, in the pre-epizootic states. These 
avoided consequences include increased public educa-
tion regarding raccoon rabies, a larger number of pre-
exposure vaccinations and post-exposure treatments, 
increased compliance rates for dog and cat vaccinations, 
increased local animal control and surveillance activi-
ties, and increased raccoon-focused wildlife manage-
ment activities. Also, laboratory staff and supply needs 
would increase costs. 
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The study estimates the benefit of avoiding epi-
zootic expansion as the sum of public and private 
expected expenses; that is, costs beyond those cur-
rently borne due to the presence of other strains of 
rabies. These are quantified in terms of cost savings, 
by comparing anticipated epizootic and post-epizootic 
costs to pre-epizootic rabies private costs and program 
expenditures. The net avoided incremental costs are 
then compared with the barrier program costs in decid-
ing whether the program is economically feasible, with 
future benefits and costs discounted to present values. 
Two rates are assumed for the spread of the epizootic 
over a 20-year time horizon: 25 miles/year (40.23km/yr) 
and 75 miles/ year (120.7 km/yr) (Fig. 1). 
In the analysis, the increase in number of pet vac-
cinations due to the epizootic is considered a forgone 
cost. Although routine pet vaccination is a regulatory 
requirement in most of the states considered here, a per-
centage of pets remains unvaccinated until imminent 
danger threatens. From a public health perspective, 
the resultant increased compliance as raccoon rabies 
becomes established is clearly good from a public health 
perspective. However, because these increased resource 
requirements would result from the emergency situa-
tion and not reflect planned action, these costs are here 
considered as private costs. Vaccination of pets is a 
major reason why few human deaths from rabies occur 
in developed countries and most jurisdictions continu-
ously allocate rabies control resources for pet vaccina-
tion services and education.
MODEL
 The model that is used has 2 major components. 
One component estimates the costs for establishing and 
maintaining the barrier, as well as other costs related 
to the proposed ORV program. The other component 
estimates the costs that would be incurred if raccoon 
rabies spread westward unchecked. 
Data on the costs associated with the raccoon 
rabies variant were collected from a variety of sources 
including previous studies (Sherman 1990, Uhaa et al. 
1992, Huntley et al. 1995, Meltzer 1996), reference lit-
erature (AVMA 1997, Bureau of the Census 1998, CDC 
1998, NASS 1998, 1999), direct contacts with people 
working with raccoon rabies and oral vaccines, and a 
pair of surveys sent out to several state public health 
veterinarians. In most cases, multiple sources were used 
to determine mean or median values that would be 
sufficiently representative of the states included in the 
analysis. Where relevant, each element was assigned 
Fig. 1. Assumed rabies spread.
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a pre-epizootic value, an epizootic value and a post-
epizootic value. 
Bait, its distribution and project evaluation costs 
are provided in Table 1. Program costs are estimated 
under the following baseline assumptions. The costs of 
potential adverse effects of the oral vaccine program 
(nontarget animals affected by consuming baits, acci-
dental human contact with the baits, etc.) are assumed 
to be zero. The effectiveness of vaccination programs 
would be validated through surveillance and testing of 
raccoon populations in the barrier zones (i.e., program 
evaluation). The evaluation cost listed also includes edu-
cational, promotional, and overhead expenses.
Table 1. Barrier and program costs.
Program cost components Unit values
Area baited 102,650 km2
Bait density 75/km2
Bait cost (Raboral V-RG®) US$1.30/unit
Aerial distribution cost US$8.62/km2
Program evaluation US$15.00/km2
The cost of the barrier is calculated annually. 
However, because the cost of maintaining the barrier is 
likely to be less than initial establishment costs, we use 
a lower value after the initial period. For the first 5 years 
we use the full program cost. This period represents a 
higher level of baiting over the entire barrier area. 
Every year thereafter we use 40% of the full program 
cost. This period represents a lower level of baiting as 
the emphasis of the program shifts primarily to monitor-
ing and spot baiting as needed. Total discounted pro-
gram costs for the planned 20-year time horizon are 
US$95,700,000.1 
Determining the costs that would be avoided by 
establishing an immune barrier is more complex. They 
are calculated by estimating the spread of the raccoon 
rabies epizootic as a uniform movement from the bar-
rier location to the Rocky Mountains (Fig. 1). For each 
year of the model, a new “slice” of the pre-epizootic 
area would be affected. Geographic Information Sys-
tems (ESRI, ArcView GIS 3.1) are used to determine 
the shape of each “slice” as well as the human popula-
tion within each of these areas. The cost of raccoon 
rabies for each area is determined by its population and 
base costs per 100,000 population (Table 2). The total 
avoided cost each year is the summation of costs that 
would be incurred in currently and previously affected 
“slices.” 
The data elements used to determine the costs 
associated with a raccoon rabies epizootic are the same 
as those used by Uhaa et al. (1992): animal-associated 
costs, human-associated costs, and other rabies-related 
expenditures. The most significant component of the 
animal cost category is the increase in pet and livestock 
vaccinations in response to a raccoon rabies epizootic. 
For dogs, this represents an increase in vaccination rates
from an average of 45% vaccinated under pre-epizootic 
conditions, to 65% in epizootic conditions, and down to 
60% in post-epizootic conditions. For cats, the vaccination 
rate is 23% before the raccoon rabies epizootic, 40% 
during the epizootic, and 25% during post-epizootic 
years. 
For livestock, less than 0.5% are vaccinated before 
an epizootic. During an epizootic, vaccination rates are 
just over 1%, and they then drop back to less than 1% 
during post-epizootic years. For this study all mamma-
lian livestock were counted together, and as a result, the 
costs may be somewhat skewed. The livestock figures 
are influenced by vaccination costs that are extremely 
low for swine, sheep, goats, and cattle, but higher for 
horses. Vaccination rates are low, but the mean cost 
per head for domestic animals overall is comparable to 
the cost of vaccinating a dog or cat. To examine the 
significance of avoided pet and livestock vaccination 
costs, they are excluded in two model variations. 
The other major elements of animal-associated 
costs deal with surveillance and monitoring of rabies 
in wildlife and domestic animals. These include labora-
Table 2. Incremental costs for the avoided cost components.
  Incremental post-
Avoided cost Incremental epizootic epizootic
component US$cost/100,000 US$cost/100,000 US$cost/unit
Pre-exposure prophylaxis 2,800 900 300
Post-exposure prophylaxis 32,600 4,200 1.50
Surveillance 6,300 4,100 n/a
Lab costs 7,600 6,800 n/a
Case investigations 6,500 8,200 n/a
Dog vaccinations 46,000 35,000 10
Cat vaccinations 44,000 13,000 10
Livestock vaccinations 10,600 6,100 10
Educational programs 21,400 21,400 n/a
1 For this analysis we use a 7% discount rate as advised by OMB circular 
No. A-94 “Guidelines and Discount Rates for Benefit-Cost Analysis of Federal 
Programs” Section 8b.
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tory diagnostic costs, the costs of preparing samples 
for testing, and animal bite investigations. Survey results 
show that the cost for laboratory diagnostics appears 
to increase significantly when raccoon rabies enters the 
epizootic stage and remains high into the post-epizootic 
stage. This may reflect not only larger numbers of ani-
mals tested, but also more detailed virus typing and 
more sophisticated rabies tests, as part of an overall 
more intensive surveillance program. 
Other animal-associated costs specified in other 
studies include those for domestic animal control and 
confinement of domestic animals suspected of having 
rabies (Uhaa et al. 1992, Huntley et al. 1995, Meltzer 
1996, Masters 1998). These costs are excluded from our 
study due to a lack of information about expenditure 
levels. Other costs or perhaps benefits not included 
in this study are the wildlife conflict costs (e.g., does 
raccoon rabies increase or decrease costs of raccoon-
related conflicts with humans?). Also not included 
here are damage, nuisance, and predation impacts on 
ground-nesting birds. These costs may be expected to 
decline as a result of rabies mortality in areas support-
ing abundant raccoon populations. If this effect does 
occur, it is likely to be short-term (1-3 years) until the 
local raccoon population recovers. Further study on this 
topic is required, including the impacts of the typically 
heightened sense of urgency associated with raccoon 
problems, independent of raccoon density, when rabies 
is documented in a specific geographic area. 
Human-associated costs include the cost of pre-
exposure vaccination and post-exposure treatment. In a 
rabies epizootic, these costs increase as more people at 
risk protect themselves against rabies through pre-expo-
sure vaccinations. Post-exposure prophylaxis increases 
as the number of potential and actual exposures to 
rabies increases (Meltzer 1996, Kreindel et al. 1998). 
Data on the cost and number of human pre- 
and post-exposure treatments were gathered primarily 
through surveys. Other costs associated with raccoon 
rabies include costs for public education, additional 
public health staffing, additional staff training, and addi-
tional administrative and clerical costs. 
The 2 cost structures shown in Table 2 represent 
the somewhat cyclical nature of a raccoon rabies epizo-
otic. Typically, when raccoon rabies enters a new area 
the epizootic can be intense for a few years, subside 
to a lower level, and then re-emerge (Trimarchi 1995, 
Meltzer 1996, CDC 1997). To account for this pattern, 
the epizootic cost structure is assumed for the first 
three years that raccoon rabies is new to an area. Subse-
quently the “post-epizootic” cost structure is used, with 
a switch back to the epizootic structure once every 5 
years for a year. 
Four model variations were evaluated. We use 25 
and 75 miles per year (mpy) for the rates at which the 
epizootic spreads westward. Additionally, we evaluated 
variations including and excluding the cost of animals 
vaccinated in response to the epizootic. Model A uses 
25 mpy and includes animal vaccination costs. Model 
B uses 25 mpy and excludes animal vaccination costs. 
Model C uses 75 mpy and includes animal vaccinations. 
Model D uses 75 mpy and excludes animal vaccinations.
RESULTS AND ANALYSIS 
Annual avoided costs (benefits) and program 
costs are discounted to present values. The final stage of 
the analysis involves comparing these discounted ben-
efits and costs. The primary decision criterion is net 
benefits or net present value (NPV). NPV is the present 
value of benefits (avoided costs) gained minus the pres-
ent value of program costs incurred. If NPV is positive, 
then the ORV program is considered economically fea-
sible. 
Net benefits for each of the 4 model variations for 
the total discounted program cost of US$95.7 million 
are economically feasible (Table 3).
Table 3. Net present values for models evaluated.a
 Net benefit
Model (US$millions)
A: 25 mpy advance (40.2 km/yr) 202
B: 25 mpy advance (40.2 km/yr), 
 no animal vac. 109
C: 75 mpy advance (127.1 km/yr) 496
D: 75 mpy advance (127.1 km/yr), 
 no animal vac. 313
aDiscount rate = 7%
To explore some alternative situations and test the 
robustness of the models, we conducted several types 
of sensitivity analysis. First, we considered a scenario 
in which the full program costs are used for the entire 
period instead of dropping to 40% after 5 years. In this 
case, the total discounted program cost for the planned 
time horizon is US$157,320,000. All of the model varia-
tions remain economically feasible (Table 4).




A: 25 mpy advance (40.2 km/yr) 141
B: 25 mpy advance (40.2 km/yr), 
 no animal vac. 48
C: 75 mpy advance (127.1 km/yr) 422
D: 75 mpy advance (127.1 km/yr), 
 no animal vac. 259
aDiscount rate = 7%
We examined the maximum program costs that 
the benefit stream would support (Table 5). This is 
the program cost at which net benefits are zero. When 
ORAL VACCINATION PROGRAM TO CONTROL RACCOON RABIES
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compared to the estimated program cost of US$95.7 mil-
lion, these maximum costs indicated that the program 
could be twice as expensive as estimated and remain 
economically feasible. 
Table 5. Largest ORV program cost that benefits could 
support.a
 Maximum program cost
Model (US$millions)
A: 25 mpy advance (40.2 km/yr) 298
B: 25 mpy advance (40.2 km/yr), 
 no animal vac. 205
C: 75 mpy advance (127.1 km/yr) 586
D: 75 mpy advance (127.1 km/yr), 
 no animal vac. 403
aEstimated program cost = US$95.7 million
To determine if the model is sensitive to the dis-
count rate of 7%, net benefits were evaluated for dis-
count rates of 5% and 10% (Table 6). As expected, net 
benefits are smaller due to the increased discount rate.
Table 6. Net benefits (NPV) for 5% and 10% discount 
rates.
Model NPV 5% NPV 10%
A: 25 mpy advance (40.2 km/yr) 281 126
B: 25 mpy advance (40.2 km/yr), 
 no animal vac. 160 60
C: 75 mpy advance (127.1 km/yr) 615 367
D: 75 mpy advance (127.1 km/yr), 
 no animal vac. 394 226
Monte Carlo Sensitivity Analysis
The Monte Carlo sampling technique was used to 
examine the robustness of model results by simulating 
assumed values of relevant parameters. The NPVs were 
estimated, running each simulation for 10,000 iterations 
using the risk analysis computer package @RISK for 
Excel (Palisade Corporation, Newfield, NY). For each 
iteration, the program selects input values at random 
from the probability distributions specified and esti-
mates the outputs (the discounted costs and NPVs) for 
the program period. From this simulated data base, vari-
ous measures of central tendency and percentiles are 
used to alleviate reliance on single point estimates. For 
example, the total baited area is expected to range 
between 84,500 and 120,800 km2, and this range can 
be more confidently applied in a simulation than a point 
estimate of 102,650 km2 (Table 7).
Lacking knowledge concerning the shape of the 
probability distribution of these input variables, we 
used the uniform and the triangular distributions to 
define uncertainty. Both of these distributions are 
among the simplest means of representing uncertainty. 
Uniform distribution is used where one can specify only 
the minimum and maximum possible values for the 
input variable. Any numerical value is equally likely to 
occur within these limits. Triangular distribution is used 
to represent the distribution of a random variable when 
the most likely value is also known. 
The average NPVs over 10,000 trials shown in 
Table 8 are close to the base calculations shown in 
Table 6. The coefficient of variation is low for all models 
tested, ranging between 0.008 and 0.038, indicating 
that the estimated values are stable (Table 8). Thus, 
the results appear to be robust, and we conclude with 
reasonable confidence that net economic benefits, in 
terms of avoided costs due to the ORV program, would 
be substantial.
Discounted program costs for the base model 
range between US$58 million and US$148 million. 
The expected cost is about US$95.6 million, while the 
median cost is about US$94.7 million. The results are 
not particularly sensitive to assumed aerial distribution 
costs. Substantially increasing the distribution cost to 
US$35 per square kilometer results in a cost range of 
between US$57 million and US$165 million, with an 
expected cost of about US$105.4 million and a median 
cost of US$104.5 million. The differences between these 
results and those of the base model are small consider-
ing the time period. The NPVs using the US$35 per km2 
for distribution costs are US$182 million, US$88.4 mil-
lion, US$476 million and US$293 million, for models A, 
B, C, and D, respectively.
CONCLUSIONS
The models presented indicate that a large scale 
ORV program, such as the one proposed, should be eco-
nomically feasible, given the program costs and avoided 
Table 7. Cost components, point estimates, probability distributions and assumed range of values.a
Program cost components Average values Probability distribution Range of values
Barrier area in km2 102,650 Uniform 84,500-120,800
Bait density/km2 75 Triangular 50-75-100
Bait cost/unit US$1.30 Uniform US$1.20-US$1.40
Aerial distribution cost/km2 US$8.62 Uniform US$6.92-US$10.32
Cost/km2 US$15.00 Uniform US$12.00-US$18.00
aThe range of values for the uniform distributions are the minimum and maximum values and those for the triangular 
distribution are the minimum, most likely, and maximum.
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cost assumptions. Results of the Monte Carlo analysis, 
even when we consider the uncertainty of values, indi-
cate that the program costs remain stable. Avoided costs 
are driven mainly by the cost of human post-exposure 
prophylaxis and pet vaccinations. Estimates for these 
variables are calculated on a per 100,000 human popula-
tion basis. As such, they depend on the speed that the 
raccoon rabies variant moves westward as well as the 
pattern and distribution of the westward spread. For 
this analysis we have used a uniform distribution and 
2 constant spread rates. As more information becomes 
available about how the variant might spread westward 
it may be possible to add sophistication to our models 
and further refine projected ORV program costs and 
benefits.
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